Comparison of extracorporeal cellular therapy (ELAD<sup>®</sup>) vs standard of care in a randomized controlled clinical trial in treating Chinese subjects with acute-on-chronic liver failure.

Hepat Med · 2018 · PMC6247955 · PMID 30532603

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Notable differences were also observed for general disorders, and administration site conditions and respiratory disorders but the intergroup differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.